We Develop Pan-Coronavirus Antivirals. There is no home therapeutic treatment for COVID-19 patients, and similarly no prophylactic treatment for at risk patients (elderly, disease preconditions, track and trace “proximity positive” individuals, family members of positive cases). Our vision is to solve this urgent unmet medical need by providing safe pan-coronavirus antivirals which can be applied by COVID-19 patients by themselves, at home.
Location: United Kingdom, England, Bristol
Employees: 1-10
Total raised: $1.9M
Founded date: 2021
Investors 2
| Date | Name | Website |
| - | Science An... | scienceang... |
| - | Empirical ... | empiricalv... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 17.05.2023 | Seed | $1.9M | - |